Lauren Brister Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

1/2018

Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauren Brister Research Topics

Disease

2	Lymphoma (Lymphomas) 10/2016 - 10/2011
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019
1	Bronchiolitis Obliterans Syndrome 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018
1	Leukemia 10/2011
1	Neoplasms (Cancer) 10/2011
1	Multiple Myeloma 10/2011

Drug/Important Bio-Agent (IBA)

1	Azacitidine (5 Azacytidine)FDA Link 01/2019
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2018

Therapy/Procedure

2	Transplantation 01/2019 - 01/2018
1	Cell Transplantation 01/2019
1	Hematopoietic Stem Cell Transplantation 10/2016
1	Autologous Transplantation 10/2016
1	Homologous Transplantation 10/2016
1	Therapeutics 10/2011